Company / Current Liabilities per Share
Kiniksa Pharmaceuticals International, plc Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.94
FY2025
5-year range
$0.76 / $1.94
FY2021-FY2025
Trend
+35.4%
vs FY2024
Sector context
#69 of 210
Health Care
What the data says
At $1.94, Kiniksa Pharmaceuticals International, plc's current liabilities per share ranks #142 of 210 in the Health Care sector. Current Liabilities per Share has increased for 3 consecutive years, from $0.76 in FY2022 to $1.94 in FY2025.
Based on SEC 10-K filings.
1.94 in FY2025 with a 5-year CAGR of +30.3%.
Increased from $0.93 to $1.94 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +36.5%
- 5-Year CAGR
- +30.3%
- 10-Year CAGR
- -
Sector benchmark
-87.7% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 35.4% year-over-year.
- Ranks #69 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.94 | +35.4% |
| FY2024 | $1.43 | +53.9% |
| FY2023 | $0.93 | +22.0% |
| FY2022 | $0.76 | -8.2% |
| FY2021 | $0.83 | +61.0% |
| FY2020 | $0.51 | +0.0% |
| FY2019 | $0.51 | -64.2% |
| FY2018 | $1.44 | -85.0% |
| FY2017 | $9.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026